The 22q11.2 deletion syndrome is a common genetic disorder that affects for example the heart, palate, immune system and hearing and therefore affects a child’s development. The purpose of this study was to investigate the proportion of children (0-18 years) with 22q11.2 deletion syndrome who have a hearing loss. A retrospective study of 103 children diagnosed with 22q11.2 deletion syndrome was conducted by medical records. Of the 103 children, 51 were boys and 52 were girls. Of all children, 54.4 % had a hearing loss according to the definition in the study. It was most common for these children to have a mild conductive hearing loss. These findings agree with other scientists’ results. The hearing measurement method used showed to be ins...
Introduction: A human being is known to have about 100 genes associated with deafness and hearing ...
Di George Syndrome, also known as velo-cardio-facial or 22q11.2 Deletion syndrome has been associate...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....
Hearing loss is frequently present in the 22q11.2 deletion syndrome. Our aim was to describe the aud...
The purpose of this study was to clarify the prevalence, type, severity, and age-dependency of heari...
Background: Hearing loss and otitis media are frequently reported in patients with 22q11.2 deletion ...
Studies of geriatric, profoundly deaf, and syndromic hearing-loss populations demonstrate significan...
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with s...
Background: The 22q11.2 deletion syndrome (22q11DS) is a genetic disorder associated with palatal ab...
Aim: The 22q11.2 deletion syndrome (22qDS) is a genetic syndrome that results in a complex physical,...
The 22q11.2 deletion syndrome (22q11.2DS) is the second most common cause of developmental delay aft...
The 22q11 deletion syndrome (22q11DS) is a genetic disorder with an estimated prevalence of 1 in 400...
Introduction and objectives: The purpose of this study was to evaluate patients diagnosed with 22q11...
Background 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome in humans. ...
The article presents own clinical observation of the chromosome 22q11.2 microdeletion syndrome in a ...
Introduction: A human being is known to have about 100 genes associated with deafness and hearing ...
Di George Syndrome, also known as velo-cardio-facial or 22q11.2 Deletion syndrome has been associate...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....
Hearing loss is frequently present in the 22q11.2 deletion syndrome. Our aim was to describe the aud...
The purpose of this study was to clarify the prevalence, type, severity, and age-dependency of heari...
Background: Hearing loss and otitis media are frequently reported in patients with 22q11.2 deletion ...
Studies of geriatric, profoundly deaf, and syndromic hearing-loss populations demonstrate significan...
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with s...
Background: The 22q11.2 deletion syndrome (22q11DS) is a genetic disorder associated with palatal ab...
Aim: The 22q11.2 deletion syndrome (22qDS) is a genetic syndrome that results in a complex physical,...
The 22q11.2 deletion syndrome (22q11.2DS) is the second most common cause of developmental delay aft...
The 22q11 deletion syndrome (22q11DS) is a genetic disorder with an estimated prevalence of 1 in 400...
Introduction and objectives: The purpose of this study was to evaluate patients diagnosed with 22q11...
Background 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome in humans. ...
The article presents own clinical observation of the chromosome 22q11.2 microdeletion syndrome in a ...
Introduction: A human being is known to have about 100 genes associated with deafness and hearing ...
Di George Syndrome, also known as velo-cardio-facial or 22q11.2 Deletion syndrome has been associate...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....